News

Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...
In an era where lifestyle related illnesses are on the rise, the integration of physical activity and balanced nutrition has ...
Researchers at Vertex Pharmaceuticals in Boston say a single infusion of stem cell-based treatment could be a permanent ...
Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...
In eusocial superorganisms like leafcutter ant colonies, labor is divvied up according to body shape and size, but University ...
Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...
An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...
A pretreatment step could help transplanted pancreatic islets survive longer in patients with type 1 diabetes, according to a ...
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...
A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 diabetes, in particular, is an irreversible lifelong autoimmune condition. But new ...
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...